Clinical and neurohormonal correlates of circulating granulocyte-macrophage colony-stimulating factor in severe heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
In this report, we showed for the first time that granulocyte-macrophage colony-stimulating factor plasma levels are elevated in patients with severe heart failure, and these levels are correlated well with neurohormonal activation and hemodynamic deterioration characterizing this syndrome.
Parissis
J T
JT
First Department of Cardiology, Amalia Fleming Hospital, Athens, Greece.
Adamopoulos
S
S
Venetsanou
K F
KF
Mentzikof
D G
DG
Karas
S M
SM
Kremastinos
D T
DT
D015415:Biomarkers / Q000097:blood; D006328:Cardiac Catheterization; D002302:Cardiac Output; D002311:Cardiomyopathy, Dilated / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood*; D006333:Heart Failure / Q000097:blood* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D011379:Prognosis; D012720:Severity of Illness Index
D015415:Biomarkers; D016178:Granulocyte-Macrophage Colony-Stimulating Factor